Skip to content
akaturk Academic measurement

OpenAlex topic

Multiple and Secondary Primary Cancers

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 1,726 works 12 author topics

Works

1,726 works

  1. YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    IMPORTANCE: Cancer is the second leading cause of death worldwide. Current estimates on the burden of cancer are needed for cancer control planning. OBJECTIVE: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 32 cancers in 1…

  2. OpenAlex top 1% OpenAlex 100.0%

    BACKGROUND: Accurate detection of lymph-node metastases in prostate cancer is an essential component of the approach to treatment. We investigated whether highly lymphotropic superparamagnetic nanoparticles, which gain access to lymph nodes by means of interstitial-lymphatic fluid transport, could be used in conjuncti…

  3. YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.6%

    Objective Recently, tumours with microsatellite instability (MSI)/defective DNA mismatch repair (dMMR) have gained considerable interest due to the success of immunotherapy in this molecular setting. Here, we aim to clarify clinical-pathological and/or molecular features of this tumour subgroup through a systematic re…

  4. YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.2%

    No abstract yet.

  5. OpenAlex top 10% OpenAlex 94.9%

    No abstract yet.

  6. OpenAlex top 1% OpenAlex 99.2%

    No abstract yet.

  7. OpenAlex top 10% OpenAlex 92.6%

    No abstract yet.

  8. YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.3%

    No abstract yet.

  9. OpenAlex 87.6%

    No abstract yet.

  10. YÖKSİS SJR Q2 JCR Q3 OpenAlex 87.6%

    No abstract yet.

  11. OpenAlex 72.3%

    During the 10-year period (1987-1996) of our study, 26,255 patients with cancer were admitted to our clinic and, of these, 271 (1%) patients had multiple primary malignant tumors. Ninety-two (34%) patients had synchronous tumors (synchronous group), and 179 (66%) patients had metachronous tumors (metachronous group).…

  12. YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.9%

    BACKGROUND: The aim of this randomized clinical trial was to evaluate the overall survival (OS) data of patients diagnosed with de novo stage IV breast cancer (BC) who received locoregional treatment (LRT) over a 10-year follow-up. STUDY DESIGN: The MF07-01 is a 1:1 multicenter, randomized clinical trial comparing the…

Academicians

12 academicians